Factors Influencing the CNS Distribution of a Novel PI3K/mTOR Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases

Data Supplement

Files in this Data Supplement:

• Supplemental Figure 1 - Plasma and brain concentrations after a 48 hour simultaneous intraperitoneal infusion of GSK2126458...